No Detail Found!

Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-resistant Nephrotic Syndrome.

Author(s)
Syed Sajid Hussain Shah Department of Paediatric Nephrology, The Children's Hospital and Institute of Child Health, Lahore, Pakistan
Farkhanda Hafeez Department of Paediatric Nephrology, The Children's Hospital and Institute of Child Health, Lahore, Pakistan
Abstract
Objective: To compare the efficacy of tacrolimus versus cyclosporine (Calcineurin Inhibitors) in the management of childhood steroid-resistant nephritic syndrome (SRNS). Study Design: Quasi-experimental study. Place and Duration of Study: Department of Paediatric Nephrology at The Children's Hospital and Institute of Child Health, Lahore, from August 2014 to September 2015. Methodology: Patients of either gender aged 1 - 12 years, with the diagnosis of mesangioproliferative glomerulonephritis (MesangioPGN), focal segmental glomerulosclerosis (FSGS) or minimal-change disease (MCD) were included. Patients were assigned into two groups, one given tacrolimus in dose of 0.1 - 0.2 mg/kg/day in two divided doses, and other given cyclosporine in dose of 150 - 200 mg/m2/day in two divided doses along with oral steroids 30 mg/m2/day in divided doses, followed by alternate day with tapering dosage. Trough drug levels were done with dose adjustment accordingly. Patients were monitored and followed for the response to treatment and adverse effects of these two calcineurin inhibitors. Results: A total of 84 patients, 58% males and 42% females, were included in the study. The age ranged from 1.25 to 12 years. The most common histopathological diagnosis was MesangioPGN (69.04%), FSGS (21.4%), and MCD (9.52%). Complete response was seen in 80.95% and 97.6% patients treated with cyclosporine and tacrolimus, respectively. Partial response was in 19.05% patients treated with cyclosporine and 2.4% in patients with tacrolimus. The most common adverse effect with cyclosporine and tacrolimus was hypertrichosis in 80.95% and 2.38%, hypertension 16.66% and 11.9% respectively while gum hypertrophy with cyclosporine was seen in 26.19% patients. Conclusion: Tacrolimus was more efficacious than cyclosporine in achieving remission in childhood SRNS with insignificant adverse effects.
Publication Details
Page(s) 589-593
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 7, Year: 2016

Request the full text from PASTIC

Keywords
Childhood steroid-resistant nephrotic syndrome. Remission. Partial response. Adverse effects. Tacrolimus. Cyclosporine. Calcineurin inhibitors.
References
MishraK,RamachandranS,FirdausS,RathB., 2015.The impact of pediatric nephrotic syndrome on parents' health-related quality of life and family functioning: An assessment made by the PedsQL 4.0 Family Impact Module,Saudi J Kidney Dis Transpl 26 285 -92
RachmadiD,MelaniA,MonnensL, 2015.NPHS2 gene mutation and polymorphisms in Indonesian children with steroid-resistant nephrotic syndrome,Open J Pediatr 5 27 -33
MubarakM,KaziJI,ShakeelS,LanewalaA,HashmiS., 2012.The spectrum of histopathological lesions in children presenting with steroid-resistant nephrotic syndrome at a single center in Pakistan,Sci World J 1 -5
AbidA,KhaliqS,ShahidS,LanewalaA,MubarakM,HashmiS, 2012.A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan,Gene 502 133 -7
BouchirebK,BoyerO,GribouvalO,NevoF,Huynh-CongE,MoriniereV, 2014.NPHS2 mutations in steroid-resistant nephrotic syndrome: A mutation update and the associated phenotypic spectrum,Hum Mutat 35 178 -86
LiX,LiH,YeH,LiQ,HeX,ZhangX, 2009.Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR,Am J Kidney Dis 54 51 -8
GulatiS,SenguptaD,SharmaRK, 2006.Steroid resistant nephrotic syndrome - role of histopathology,Indian Pediatr 43 55 -60
TryggvasonK,PetterssonE, 2003.Causes and consequences of proteinuria: The kidney filtration barrier and progressive renal failure,J Intern Med 254 216 -24
ZivoticM,BogdanovicR,Peco-AnticA,ParipovicD,StajicN,VjesticaJ, 2015.Glomerular nestin expression: Possible predictor of outcome of focal segmental glomerulosclerosis in children,Pediatr Nephrol 30 79 -90
DieguezLM,BouhassiraD,GipsonD,TrachtmanH, 2015.Novel therapies for FSGS: Preclinical and clinical studies,Adv Chronic Kidney Dis 22 e1 -e6
HabashyD,HodsonEM,CraigJC, 2003.Interventions for steroidresistant nephrotic syndrome: A systematic review,Pediatr Nephrol 18 906 -12
MagnascoA,RavaniP,EdefontiA,MurerL,GhioL,BelingheriM, 2012.Rituximab in children with resistant idiopathic nephrotic syndrome,J Am Soc Nephrol 23 1117 -24
HusenMV,Kemper MJ, 2011.New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome,Pediatr Nephrol 26 881 -92
ChoudhryS,BaggaA,HariP,SharmaS,KalaivaniM,DindaA, 2009.Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: A randomized controlled trial,Am J Kidney Dis 53 760 -9
ButaniL,RamsamoojR, 2009.Experience with tacrolimus in children with steroid-resistant nephrotic syndrome,Pediatr Nephrol 24 1517 -23
WangW,XiaY,MaoJ,ChenY,WangD,ShenH, 2012.Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome,Pediatr Nephrol 27 2073 -9
HamasakiY,YoshikawaN,NakazatoH,SasakiS,IijimaK,NakanishiK, 2013.Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis,Pediatr Nephrol 28 765 -71
RobertiI, 2010.Vyas S. Long-term outcome of children with steroidresistant nephrotic syndrome treated with tacrolimus,Pediatr Nephrol 25 1117 -24
GulatiA,SinhaA,GuptaA,KanitkarM,SreenivasV,SharmaJ, 2012.Treatment with tacrolimus and prednisolone ispreferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome,Kidney Int 82 1130 -5
JahanA,PrabhaR,ChaturvediS,MathewB,FlemingD,AgarwalI., 2015.Clinical efficacy and pharmaco-kinetics of tacrolimus in children with steroid-resistant nephrotic syndrome,Pediatr Nephrol 30 1961 -7
KlaassenI,ÖzgörenB,SadowskiCE,MöllerK,van HusenM,LehnhardtA, 2015.Response to cyclosporine in steroidresistant nephrotic syndrome: discontinuation is possible,Pediatr Nephrol 30 1477 -83
InabaA,HamasakiY,IshikuraK,HamadaR,SakaiT,HatayaH, 2015.Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children,Pediatr Nephrol 1 -10
SamuelS,BitzanM,ZappitelliM,DartA,MammenC,PinskM, 2014.Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for glomerulonephritis: Management of nephrotic syndrome in children,Am J Kidney Dis 63 354 -62
LanewalaA,MubarakM,KaziJI,AkhterF,SherA,FayyazA, 2012.A Clinicopathologic study of primary focal segmental glomerulosclerosis in children,Saudi J Kidney Dis Transpl 23 513 -20
ShakeelS,MubarakM,KaziJI,LanewalaAli, 2012.The prevalence and clinicopathological profile of IgM nephropathy in children with steroid-resistant nephrotic syndrome at a single centre in Pakistan,J Clin Pathol 65 1072 -6
0

Citations

0

Downloads

76

Views